The following Abilify side effects findings are based on a pool of five placebo-controlled trials (four 4-week and one 6-week) in which aripiprazole was administered in doses ranging from 2 to 30 mg/day.
Adverse Events (side effects) Associated with Discontinuation of Abilify Treatment in Short-Term, Placebo-Controlled Trials:
Overall, there was no difference in the incidence of discontinuation due to adverse events between aripiprazole-treated (7%) and placebo-treated (9%) patients. The types of adverse events that led to discontinuation were similar between the aripiprazole and placebo-treated patients.
Adverse Events (side effects) Occurring at an Incidence of 2% or More Among Abilify-Treated Patients and Greater than Placebo in Short-Term Placebo-Controlled Trials:
There may be additional Abilify side effects.
Buy Abilify